FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

36805311000001106: Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Mar 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112830301000001118 Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112830401000001114 Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Is a Product containing precisely hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has basis of strength substance Valsartan true Inferred relationship Existential restriction modifier 2
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has basis of strength substance Hydrochlorothiazide true Inferred relationship Existential restriction modifier 1
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has presentation strength numerator value 25 false Inferred relationship Existential restriction modifier 1
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has presentation strength numerator value 160 false Inferred relationship Existential restriction modifier 2
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has precise active ingredient Valsartan true Inferred relationship Existential restriction modifier 2
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has precise active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier 1
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has specific active ingredient Valsartan true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) 28 tablet 2 x 14 tablets Has AMP True Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start